Tissue inhibitor of metalloproteinases 1 (TIMP1) serves as an early detection and prognosis biomarker for aggressive lung cancer—its serum level correlates with tumor burden and survival in mice, and has been validated in clinical samples [14]. This evidence concerns the gene TIMP1 and lung carcinoma.